Board Meeting Announcement for Genomic Valley Biotech Ltd - Dec 6, 2024

Inter alia, to consider the following items: a) To consider and Approve the Director's Report of the Board of Director of the company for the Financial Year 2023-24. b) To Consider and Approve the date, time, venue and mode for convening the 30th Annual General Meeting of the Company. c) To consider and approve to appoint SBR & Co. LLP, Company Secretaries, as Scrutinizer for the ensuing Annual General Meeting. d) To consider any other business with the permission of the chair